Invivyd (IVVD) Change in Accured Expenses (2021 - 2025)

Invivyd (IVVD) posted Change in Accured Expenses of -$6.0 million for Q4 2025, up 75.77% on a QoQ basis from -$24.8 million in Q3 2025, and up 15.05% year-over-year from -$5.2 million in Q4 2024.

Invivyd (IVVD) Change in Accured Expenses (2021 - 2025) Analysis & Trends

Invivyd's Change in Accured Expenses history runs 5 years deep, the most recent figure standing at -$6.0 million for Q4 2025.

  • Quarterly Change in Accured Expenses rose 15.05% year-over-year to -$6.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$30.8 million (down 444.66% YoY) and the FY2025 annual result came in at -$30.8 million, down 444.66% from the prior year.
  • Change in Accured Expenses was -$6.0 million for Q4 2025 at Invivyd, up from -$24.8 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $51.4 million in Q4 2021 and bottomed at -$24.8 million in Q3 2025.
  • A 5-year average of $2.4 million and a median of -$61500.0 in 2022 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2022 — Change in Accured Expenses slumped 333.06% — and 2024, when it soared 265541.67%.
  • Invivyd's Change in Accured Expenses stood at $51.4 million in 2021, then sank by 99.81% to $97000.0 in 2022, then soared by 19673.2% to $19.2 million in 2023, then tumbled by 136.92% to -$7.1 million in 2024, then climbed by 15.05% to -$6.0 million in 2025.
  • Business Quant data shows IVVD's Change in Accured Expenses at -$6.0 million in Q4 2025, -$24.8 million in Q3 2025, and $10.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 1.13 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 931,000.00
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -16.82 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -16.74 Mn
10 Invivyd 104.07 Mn -122.62 Mn 16.07 Mn -6.02 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -6.02 Mn
Dec 31, 2025 -6.02 Mn
Sep 30, 2025 -24.83 Mn
Sep 30, 2025 -24.83 Mn
Jun 30, 2025 10.01 Mn
Jun 30, 2025 10.01 Mn
Mar 31, 2025 -10.01 Mn
Mar 31, 2025 -10.01 Mn
Dec 31, 2024 -7.08 Mn
Dec 31, 2024 -7.08 Mn
Sep 30, 2024 31.85 Mn
Sep 30, 2024 31.85 Mn
Jun 30, 2024 -8.86 Mn
Jun 30, 2024 -8.86 Mn
Mar 31, 2024 -6.96 Mn
Mar 31, 2024 -6.96 Mn
Dec 31, 2023 19.18 Mn
Dec 31, 2023 19.18 Mn
Sep 30, 2023 -12,000.00
Sep 30, 2023 -12,000.00